JD Health VP Huang Guojun: Health Is No Longer Just About Buying Medicine, Technology Needed to Address Unmet Needs

Deep News
11/12

On the afternoon of November 12, at the 17th Caixin Summit themed "Adapting to Development and Changing Circumstances," JD Health (HK: 06618) Vice President and General Manager of Consumer Healthcare Business Huang Guojun delivered a speech in response to the question of "what changes have occurred in people's health consumption needs." He stated that currently, "health" no longer equals "buying medicine" — the two have become separate concepts.

Specifically, first, pharmacies used to be shelves, but today pharmacies need to operate an ecosystem that includes both medicines and health supplements. Second, in the past, it was doctors who recommended medicines, but now social media influencers and others can also make recommendations, giving consumers a more thorough understanding of their medicine choices. Third, buying medicine used to be a one-time action, but now it is a long-term behavior — not solving a single problem, but addressing issues extending from conditions like blood sugar and blood lipids.

Huang Guojun introduced that JD Health is currently deploying physical examination centers on a large scale offline, using physical spaces for health display and education. On the other hand, people who participate in health data collection offline may shift to online to purchase extended services. Online and offline show a highly positive correlation.

At the same time, he stated that health is no longer just physical examination indicators, but rather people's need to become better. Therefore, technology must be used to address unmet health needs. JD Health has already transformed this demand into services such as medical aesthetics, traditional Chinese medicine, and dental care, which further drives JD Health to achieve comprehensive medical capability transformation.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10